Recent Events & Catalysts
Tempus AI, Inc. (TEM) — real, dated facts. Not a claim about what caused any single day's price move.
Committee Signals
Proprietary signals generated by the Innellis AI committee — score changes, rating shifts, and analyst disagreements.
No committee signals recorded yet.
News
Why Is Tempus AI Stock Surging on Friday?
Benzinga · 4d ago
Caris Life Sciences: Guidance Raised, Valuation Still Attractive
SeekingAlpha · 4d ago
CellCarta To Include Tempus In CDx Commercialization Lab Network As Network's Second Commercial Laboratory Partner, Enhancing Oncology Companion Diagnostics For Biopharma
Benzinga · 5d ago
The BioRevolution Has Accelerated
SeekingAlpha · 6d ago
Piper Sandler Maintains Neutral on Tempus AI, Lowers Price Target to $56
Benzinga · 7d ago
Tempus AI Announces Publication Of Study Results In 'Nature Medicine' That Demonstrate The PRISM2 Pathology Foundation Model's Ability To Perform Clinically Important Diagnostic Tasks
Benzinga · 7d ago
BTIG Maintains Buy on Tempus AI, Lowers Price Target to $70
Benzinga · 8d ago
HC Wainwright & Co. Maintains Buy on Tempus AI, Lowers Price Target to $56
Benzinga · 8d ago
SEC Filings (90 days)
Results of operations (earnings release), Regulation FD disclosure, Financial statements and exhibits
Filed 2026-07-30 · 12d ago · Material
Entry into a material agreement, Financial statements and exhibits
Filed 2026-07-20 · 22d ago
Regulation FD disclosure, Financial statements and exhibits
Filed 2026-07-20 · 22d ago
Submission of matters to a vote of security holders
Filed 2026-05-22 · 81d ago
Entry into a material agreement, Termination of a material agreement, Creation of a direct financial obligation (new debt), Unregistered sales of equity securities, Other events, Financial statements and exhibits
Filed 2026-05-13 · 90d ago
Earnings
No recent earnings data available.
Latest Analyst Action
No recent analyst actions available.